Intercept Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ICPT Intercept Pharmaceuticals Inc
ALMMF Aluminum Corp of China Ltd
FUN Cedar Fair LP
BAC Bank of America Corp
XLF Financial Select Sector SPDR® Fund
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
BIIB Biogen Inc
CNF CNFinance Holdings Ltd
LVS Las Vegas Sands Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). In addition to OCA, it is developing other bile acid analog compounds targeting FXR and a second dedicated bile acid receptor called TGR5, which is a target of interest for the treatment of type 2 diabetes and other gastrointestinal indications. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.

Closing Price
$47.09
Day's Change
0.57 (1.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
47.24
Day's Low
45.08
Volume
(Light)
Volume:
1,126,208

10-day average volume:
1,989,365
1,126,208
  • Prev Close
    46.52
  • Today's Open
    47.21
  • Day's Range
    45.08-47.24
  • Avg Vol (10-day)
    2.0M
  • Last (time)
    4:00p ET 07/02/20
  • Last (size)
    5
  • 52-Wk Range
    44.50 - 125.00
    LowHigh
  • (12/31/19 - 06/29/20)
    5.82%
  • 85.3%
  • Market Cap
    1.6B
  • Shares Outstanding
    32.9M
  • -10.72
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.8
  • 76.74
  • (% of float 06/15/20)
    22.12

Latest News

June 30, 2020
9:06 pm ET
BusinessWire
9:07 am ET
MarketWatch
7:53 am ET
MarketWatch
6:11 am ET
MarketWatch
June 29, 2020
6:00 pm ET
BusinessWire
4:00 pm ET
BusinessWire
7:26 am ET
MarketWatch
7:24 am ET
MarketWatch
7:17 am ET
MarketWatch
7:15 am ET
MarketWatch
7:15 am ET
MarketWatch
7:00 am ET
Globe Newswire
June 16, 2020
3:41 pm ET
Globe Newswire
June 08, 2020
5:49 pm ET
Globe Newswire
June 05, 2020
8:35 am ET
MarketWatch
June 01, 2020
6:09 pm ET
Globe Newswire
May 22, 2020
8:00 am ET
Globe Newswire
May 11, 2020
7:00 am ET
Globe Newswire
May 06, 2020
8:30 am ET
Globe Newswire
April 27, 2020
8:25 am ET
Globe Newswire
April 08, 2020
8:38 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.